Page last updated: 2024-12-11
st 232
Description
Research Excerpts
Clinical Trials
Roles
Classes
Pathways
Study Profile
Bioassays
Related Drugs
Related Conditions
Protein Interactions
Research Growth
Market Indicators
Description
26,26,26,27,27,27-hexafluoro-1,23,25-trihydroxyvitamin D3: RN given refers to (1alpha,3beta,5Z,7E,23S)-isomer; RN for cpd without isomeric designation not avail 12/92 [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]
Cross-References
| ID Source | ID |
|---|---|
| PubMed CID | 6439245 |
| SCHEMBL ID | 19988244 |
| MeSH ID | M0467576 |
Synonyms (14)
| Synonym |
|---|
| 9,10-secocholesta-5,7,10(19)-triene-1,3,23,25-tetrol, 26,26,26,27,27,27-hexafluoro-, (1-alpha,3-beta,5z,7e,23s)- |
| 9,10-secocholesta-5,7,10(19)-triene-1,3,23,25-tetrol-26,26,26,27,27,27-hexafluoro-, (1alpha,3beta,5z,7e,23s)- |
| 26,26,26,27,27,27-hexafluoro-1,23,25-trihydroxyvitamin d3 |
| st 232 |
| 8u88au88ik , |
| st-232 |
| 26,26,26,27,27,27-hexafluoro-1alpha,23s,25-trihydroxyvitamin d3 |
| unii-8u88au88ik |
| st232 cpd |
| sm-10193 |
| 114489-80-4 |
| (1r,5z)-5-[(2e)-2-[(1r,7ar)-7a-methyl-1-[(2r)-7,7,7-trifluoro-4,6-dihydroxy-6-(trifluoromethyl)heptan-2-yl]-2,3,3a,5,6,7-hexahydro-1h-inden-4-ylidene]ethylidene]-4-methylidenecyclohexane-1,3-diol |
| SCHEMBL19988244 |
| svmoccgipididm-iwzdejhgsa-n |
Research Excerpts
Dosage Studied
| Excerpt | Relevance | Reference |
|---|---|---|
| "6 times higher at 6, 24, and 48 h postdosing than after dosing with [1beta-3H] 1alpha,25(OH)2 vitamin D3." | ( Disposition and metabolism of F6-1alpha,25(OH)2 vitamin D3 and 1alpha,25(OH)2 vitamin D3 in the parathyroid glands of rats dosed with tritium-labeled compounds. Kanamaru, H; Komuro, S; Sato, M, 2003) | 0.32 |
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]
Research
Studies (8)
| Timeframe | Studies, This Drug (%) | All Drugs % |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 3 (37.50) | 18.2507 |
| 2000's | 5 (62.50) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| [information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] | ||
Market Indicators
Research Demand Index: 36.35
According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be strong demand-to-supply ratio for research on this compound.
| This Compound (36.35) All Compounds (24.57) |
Study Types
| Publication Type | This drug (%) | All Drugs (%) |
|---|---|---|
| Trials | 0 (0.00%) | 5.53% |
| Reviews | 1 (12.50%) | 6.00% |
| Case Studies | 0 (0.00%) | 4.05% |
| Observational | 0 (0.00%) | 0.25% |
| Other | 7 (87.50%) | 84.16% |
| [information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] | ||